Consultant psychiatrist for Adult neurodevelopemental disorders

UKAAN Lead for the North East of England

Member of CADDRA research committee

Sub I PAX-BD - pramiprexole in depression study.

PI for digital medicines trial

PI for Ketamine in ECT trial

PI for LQD trial (TEWV)

Sub I Intranasal ketamine  study

New projects to be commenced

CI for UK Landscape study

PI for SNAPPER Study

Co investigator for multimodal sensing in ADHD (funding submitted)

Honorary Fellow Newcastle University

Educational supervisor for FY1 trainees

Clinical supervisor for Core trainees

Clinical supervisor for CESR fellow

Clinical supervisor for Overseas Fellowship scheme

Clinical supervisor for Physician associate students

Clinical supervisor for Nurse medical prescribers

Clinical examiner for CASC exam conducted by Royal college of psychiatrists

Educational supervision for third and fifth year medical students

• Trevithick L, McAllister-Williams RH, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Ellwell C, Hayden K, Holland F, Karim S, Lowe J, Loo C, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, Anderson IM. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study). BMC Psychiatry 2015, 15, 257.
• Nair R, Reading R, Killilea k. Great Imitator. Journal of Neurology, Neurosurgery and Psychiatry 2015, 86, e3.
• Bhogal K, Baldwin DS, Hartland L, Nair R. Differences between ethnic groups in demographic and clinical features of patients admitted and assessed after deliberate self-harm. International Journal of Social Psychiatry 2006, 52(6), 483-486.
• Baldwin S, Nair R. Escitalopram in the treatment of generalized anxiety disorder. Expert Opinion in Neurotherapeutics 2005, 5(4), 443-449.
• Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Loo C, Lowe J, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): A multicentre, double-blind, randomised, parallel-group, superiority trial. The Lancet Psychiatry 2017, 4(5), 365-377.
• Gupta S, Lakshmanan D, Khastgir u, Nair R. Management of antipsychotic-induced hyperprolactinaemia. BJPsych Advances 2017, 23(4), 278-286.
• Marwood l, Taylor R, Goldsmith K, Romeo R, Holland R, Pickles A, Hutchinson J, Dietch D, Cipriani A, Nair R, Attenburrow MJ, Young AH, Geddes J, McAllister-Williams RH, Cleare AJ. Study Protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of Lithium and quetiapine augmentation in treatment resistant depression (the LQD study). BMC Psychiatry 2017, 17, 231.
• Palmos AB, Watson S, Hughes T, Finkelmeyer A, McAllister-Williams RH, Ferrier N, Anderson IM, Nair R, Young AH, Strawbridge R, Cleare AJ, Chung R, Frissa S, Goodwin L, Hotopf M, Hatch SL, Wang H, Collier DA, Thuret S, Breen G, Powell TR. Associations between childhood maltreatment and inflammatory markers. BJ Psych Open 2019, 5(1), e3.